G61.0 Billable / specific Guillain-Barre syndrome
ICD-10-CM G61.0 identifies “Guillain-Barre syndrome” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 6: Diseases of the nervous system
Code-level instructions
Inclusion terms2
- Acute (post-)infective polyneuritis
- Miller Fisher Syndrome
Inherited instructions
Chapters 6 · Diseases of the nervous system (G00-G99)
Excludes 28
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
G60-G65 · Polyneuropathies and other disorders of the peripheral nervous system (G60-G65)
Official index references
Official index references (27)
Barré-Guillain disease or syndrome (1)
- Barré-Guillain disease or syndromeDisease index
Disease, diseased (2)
- Disease, diseased › Guillain-BarréDisease index
- Disease, diseased › Landry'sDisease index
Encephalomyeloradiculitis(acute) (1)
- Encephalomyeloradiculitis(acute)Disease index
Encephalomyeloradiculoneuritis(acute) (Guillain-Barré) (1)
Guillain-Barré disease or syndrome (1)
- Guillain-Barré disease or syndromeDisease index
Landry-Guillain-Barré, syndrome or paralysis (1)
- Landry-Guillain-Barré, syndrome or paralysisDisease index
Landry's disease or paralysis (1)
- Landry's disease or paralysisDisease index
Miller Fisher syndrome (1)
- Miller Fisher syndromeDisease index
Neuritis(rheumatoid) (2)
- Neuritis(rheumatoid) › infectious(multiple) NECDisease index
- Neuritis(rheumatoid) › multiple › infective, acuteDisease index
Neuromyelitis (1)
- Neuromyelitis › ascendingDisease index
Ophthalmoplegia (1)
- Ophthalmoplegia › ataxia-areflexiaDisease index
Paralysis, paralytic(complete) (incomplete) (3)
Polyneuritis, polyneuritic (5)
- Polyneuritis, polyneuritic › acute(post-)infectiveDisease index
- Polyneuritis, polyneuritic › febrile, acuteDisease index
- Polyneuritis, polyneuritic › idiopathic, acuteDisease index
- Polyneuritis, polyneuritic › infective(acute)Disease index
- Polyneuritis, polyneuritic › postinfective(acute)Disease index
Polyradiculoneuropathy(acute) (postinfective) (segmentally demyelinating) (1)
Sclerosis, sclerotic (1)
Syndrome (4)
- Syndrome › Barré-GuillainDisease index
- Syndrome › Fisher'sDisease index
- Syndrome › Guillain-Barré(-Strohl)Disease index
- Syndrome › Miller-FisherDisease index
History
Code history
No recorded change since first observation
ChangedUnchanged
FY2016
Effective from
- First observed
Guillain-Barre syndrome
Billable diagnosis code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 357.0
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.